To Compare Efficacy Of The Injection Propofol Vs Injection Etomidate During General Anaesthesia In Adult Group

To Compare Efficacy Of The Injection Propofol Vs Injection Etomidate During General Anaesthesia In Adult - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/097089

Enrollment

150

Registered

2025-11-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K272- Acute peptic ulcer, site unspecified, with both hemorrhage and perforation Health Condition 2: O- Medical and Surgical Health Condition 3: N648- Other specified disorders of breast Health Condition 4: H679- Otitis media in diseases classified elsewhere, unspecified ear Health Condition 5: M479- Spondylosis, unspecified Health Condition 6: K37- Unspecified appendicitis

Interventions

Intervention1: Inj Propofol 2mg/kg intravenous. : Inj Propofol will be given to patients Control Intervention1: Inj Etomidate 0.3mg/kg intravenous: Inj Etomidate will be given to patients.

Eligibility

Inclusion criteria

Inclusion criteria: ASA Grade 1 and 2 Elective surgeries under general anaesthesia

Exclusion criteria

Exclusion criteria: Hypersensitivity to drug Pregnancy and lactation Patient refusal for participation in study

Design outcomes

Primary

Measure	Time frame
To Check The Effect Of Injection Propofol And Injection EtomidateTimepoint: From Starting Of Induction,Intra-op And Post-op Up To 10 Minutes	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDR RAGHU DHIRUBHAI SURANI

Gujrat adani institute of medical science

nirali_7291@yahoo.in94261 38081

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026